Accendra Health (ACH) Cash from Financing Activities (2009 - 2026)

Accendra Health (ACH) has 18 years of Cash from Financing Activities data on file, last reported at $51.1 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $51.1 million, down 44.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $146.4 million (up 164.16% YoY), and the FY2025 annual result was $188.1 million, up 170.28% from the prior year.
• Cash from Financing Activities climbed to $51.1 million in Q1 2026 per ACH's latest filing, from -$117.5 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $1.7 billion in Q1 2022 and troughed at -$199.6 million in Q3 2024.
• A 5-year average of $61.8 million and a median of -$51.2 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities jumped 2170.05% in 2022, then sank 812.78% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$63.5 million in 2022, then gained by 19.32% to -$51.2 million in 2023, then gained by 15.85% to -$43.1 million in 2024, then plunged by 172.64% to -$117.5 million in 2025, then jumped by 143.48% to $51.1 million in 2026.
• Business Quant data shows ACH's Cash from Financing Activities at $51.1 million in Q1 2026, -$117.5 million in Q4 2025, and $181.1 million in Q3 2025.